Nexalin Technology Stock Buy Hold or Sell Recommendation
| NXL Stock | USD 2.15 0.20 10.26% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Nexalin Technology is 'Cautious Hold'. The recommendation algorithm takes into account all of Nexalin Technology's available fundamental, technical, and predictive indicators you will find on this site.
Check out Nexalin Technology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide. Note, we conduct extensive research on individual companies such as Nexalin and provide practical buy, sell, or hold advice based on investors' constraints. Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Nexalin |
Execute Nexalin Technology Buy or Sell Advice
The Nexalin recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nexalin Technology. Macroaxis does not own or have any residual interests in Nexalin Technology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nexalin Technology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Nexalin Technology Trading Alerts and Improvement Suggestions
| Nexalin Technology generated a negative expected return over the last 90 days | |
| Nexalin Technology has high historical volatility and very poor performance | |
| Nexalin Technology has high likelihood to experience some financial distress in the next 2 years | |
| Nexalin Technology has 4.46 K in debt. Nexalin Technology has a current ratio of 0.2, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Nexalin to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 110.75 K. Reported Net Loss for the year was (4.65 M) with profit before taxes, overhead, and interest of 127.75 K. | |
| Nexalin Technology has about 291.33 K in cash with (3.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Nexalin Technology has a frail financial position based on the latest SEC disclosures | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from simplywall.st: Nuix Limiteds 29 percent Dip Still Leaving Some Shareholders Feeling Restless Over Its PSRatio |
Nexalin Technology Returns Distribution Density
The distribution of Nexalin Technology's historical returns is an attempt to chart the uncertainty of Nexalin Technology's future price movements. The chart of the probability distribution of Nexalin Technology daily returns describes the distribution of returns around its average expected value. We use Nexalin Technology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nexalin Technology returns is essential to provide solid investment advice for Nexalin Technology.
| Mean Return | -0.83 | Value At Risk | -13.03 | Potential Upside | 10.76 | Standard Deviation | 6.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nexalin Technology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nexalin Technology Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (1.1K) | (8.8K) | (142.9K) | (7.8K) | (7.0K) | (7.4K) | |
| Change In Cash | 15.0K | 583.3K | (499.0K) | 417.5K | 480.1K | 504.1K | |
| Free Cash Flow | (864.1K) | (1.1M) | (2.2M) | (3.9M) | (3.6M) | (3.4M) | |
| Other Non Cash Items | 8.8K | 4.1M | (155.0K) | (835.4K) | (751.9K) | (714.3K) | |
| Net Income | (3.4M) | (6.1M) | (1.7M) | (4.6M) | (5.3M) | (5.6M) | |
| End Period Cash Flow | 78.4K | 661.8K | 162.7K | 580.2K | 667.3K | 340.3K |
Nexalin Technology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nexalin Technology or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nexalin Technology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nexalin stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.58 | |
β | Beta against Dow Jones | 2.39 | |
σ | Overall volatility | 6.93 | |
Ir | Information ratio | -0.11 |
Nexalin Technology Volatility Alert
Nexalin Technology is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nexalin Technology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nexalin Technology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Nexalin Technology Fundamentals Vs Peers
Comparing Nexalin Technology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nexalin Technology's direct or indirect competition across all of the common fundamentals between Nexalin Technology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nexalin Technology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nexalin Technology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nexalin Technology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nexalin Technology to competition |
| Fundamentals | Nexalin Technology | Peer Average |
| Return On Equity | -1.36 | -0.31 |
| Return On Asset | -0.84 | -0.14 |
| Operating Margin | (69.62) % | (5.51) % |
| Current Valuation | 23 M | 16.62 B |
| Shares Outstanding | 13.3 M | 571.82 M |
| Shares Owned By Insiders | 19.22 % | 10.09 % |
| Shares Owned By Institutions | 2.88 % | 39.21 % |
| Number Of Shares Shorted | 355.87 K | 4.71 M |
| Price To Book | 5.23 X | 9.51 X |
| Price To Sales | 176.47 X | 11.42 X |
| Revenue | 110.75 K | 9.43 B |
| Gross Profit | 127.75 K | 27.38 B |
| EBITDA | (5.69 M) | 3.9 B |
| Net Income | (4.65 M) | 570.98 M |
| Cash And Equivalents | 291.33 K | 2.7 B |
| Cash Per Share | 0.06 X | 5.01 X |
| Total Debt | 4.46 K | 5.32 B |
| Current Ratio | 0.20 X | 2.16 X |
| Book Value Per Share | 0.39 X | 1.93 K |
| Cash Flow From Operations | (3.84 M) | 971.22 M |
| Short Ratio | 0.99 X | 4.00 X |
| Earnings Per Share | (0.65) X | 3.12 X |
| Target Price | 3.0 | |
| Number Of Employees | 6 | 18.84 K |
| Beta | 4.39 | -0.15 |
| Market Capitalization | 28.6 M | 19.03 B |
| Total Asset | 3.63 M | 29.47 B |
| Retained Earnings | (77.04 M) | 9.33 B |
| Working Capital | 3 M | 1.48 B |
| Net Asset | 3.63 M |
Note: Acquisition by White Gregory of 150 shares of Nexalin Technology subject to Rule 16b-3 [view details]
Nexalin Technology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nexalin . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nexalin Technology Buy or Sell Advice
When is the right time to buy or sell Nexalin Technology? Buying financial instruments such as Nexalin Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nexalin Technology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Repeal Thematic Idea Now
Obamacare Repeal
Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. The Obamacare Repeal theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Repeal Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Nexalin Technology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Revenue Per Share | Quarterly Revenue Growth 0.494 | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.